Synthesis of new troglitazone derivatives: Anti-proliferative activity in breast cancer cell lines and preliminary toxicological study

Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells <i>in vitro</i> and in BNX mice

Elena Elstner, Carsten Müller‐Tidow, Kozo Koshizuka et al. · Proceedings of the National Academy of Sciences · 1998 · 795 citations · Full text

Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours

Gregory Russell‐Jones, Kirsten J. McTavish, John McEwan et al. · Journal of Inorganic Biochemistry · 2004 · 379 citations

Drug Targeting, Medicine, Pharmacology +9

Targeting cancer cells with biotin–dendrimer conjugates

Wenjun Yang, Yiyun Cheng, Tongwen Xu et al. · European Journal of Medicinal Chemistry · 2008 · 288 citations

Tumor Targeting, Cancer Cells, Dendritic Cell Biology +4

Use of the Peroxisome Proliferator-Activated Receptor (PPAR) γ Ligand Troglitazone as Treatment for Refractory Breast Cancer: A Phase II Study

Harold J. Burstein, George D. Demetri, Elisabetta Mueller et al. · Breast Cancer Research and Treatment · 2003 · 224 citations

Ligand Troglitazone, Breast Oncology, Medicine +10

Thiazolidenediones Mediate Apoptosis in Prostate Cancer Cells in Part through Inhibition of Bcl-xL/Bcl-2 Functions Independently of PPARγ

Chung-Wai Shiau, Chih-Cheng Yang, Samuel K. Kulp et al. · Cancer Research · 2005 · 216 citations

Chemoprevention Strategy, Apoptosis, Cell Death +18